Related Experiment Video
Updated: Nov 7, 2025
10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.5K
Advanced Ovarian Cancer during Pregnancy. Tumour Evolution Analysis and Treatment Approach
Ana Isabel Bueno Moral1, Jose Carlos Vilches Jiménez1, Adriana Serrano Olave1
1Department of Obstetrics and Gynaecology, Regional University Hospital, 29011 Málaga, Spain.
Medicina (Kaunas, Lithuania)
|April 30, 2021
Summary
Diagnosing ovarian cancer during pregnancy is crucial. Early detection and treatment of adnexal masses improve outcomes for both mother and child.
Area of Science:
- Oncology
- Obstetrics
- Gynecology
Background:
- Malignant adnexal masses must be considered during pregnancy.
- Routine obstetric ultrasounds can aid in early diagnosis of asymptomatic ovarian cancer.
Observation:
- A 27-year-old pregnant patient at 20 weeks gestation presented with an adnexal tumor and enlarged supraclavicular lymph nodes.
- The patient was diagnosed with metastatic low-grade papillary serous ovarian carcinoma.
Findings:
- Neoadjuvant chemotherapy was initiated, followed by an elective Cesarean section at 34 weeks.
- A healthy female infant weighing 2040g was delivered, and the mother is undergoing continued medical oncology follow-up.
Implications:
- Early diagnosis of gynecologic malignancies in pregnancy is critical.
- Timely management of early-stage carcinomas enhances maternal and fetal well-being.
- Early intervention offers more treatment alternatives for pregnant patients with cancer.
Related Concept Videos
01:21Cancer Survival Analysis
497
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
497
02:07Tumor Progression
6.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.8K
02:56Treatment Resistant Cancers
3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
02:07Oogenesis
67.3K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
67.3K